-
Mashup Score: 1
The tremendous potential of stem cells to treat a wide range of diseases has captured the imaginations of patients, practitioners, scientists and entrepreneurs worldwide for decades. However, despite being widely marketed to the public for their regenerative properties and their promise to revolutionize medicine, stem cell therapies often carry claims that far exceed the known benefits. At best, the procedures are largely ineffective, and at worst, patients are exposed to severe health complications.
Source: www.bakerinstitute.orgCategories: Cardiologists, Latest HeadlinesTweet
-
Mashup Score: 5Getting back to normal by Oct. 1? - 4 year(s) ago
Fellow Peter Hotez has a plan for opening America by Oct. 1. It will “force America to make some difficult choices, but none as devastating as the mounting deaths if we choose to simply stay the course.” Science Direct: bit.ly/39rjve3
Source: www.bakerinstitute.orgCategories: Healthcare Professionals, Latest HeadlinesTweet
-
Mashup Score: 1Statistics warn of a worsening trend if risks are not managed - 4 year(s) ago
Coronavirus cases in Texas may grow as the state expands COVID-19 screening and delayed decisions to limit public interactions have serious consequences. “No one should be surprised lim or panic as the figures roll out,” write the authors in the Baker Institute Blog.
Source: www.bakerinstitute.orgCategories: Hem/OncsTweet
Had a great time visiting @Texas_Heart and my alma mater @RiceUniversity to discuss the future of cell therapy and what’s needed next for #clinicaltrials https://t.co/nJJdIeZpJ3 @BakerInstitute